He lurbinectedin market is centered on its use in oncology, particularly for the treatment of small cell lung cancer. Increasing cancer prevalence and demand for novel chemotherapeutic agents are driving market growth. Lurbinectedin’s targeted mechanism and clinical efficacy are supporting its adoption. https://www.databridgemarketresearch.com/reports/global-lurbinectedin-market